Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.
Transplantation. 2012 Sep 15;94(5):478-85. doi: 10.1097/TP.0b013e31825c5967.
Innate immunity plays a role in controlling adaptive immune responses.
We investigated the clinical relevance of single nucleotide polymorphisms in 22 genes encoding innate, secreted, and signaling pattern recognition receptors in a total of 520 donor-recipient pairs of postmortem, human leukocyte antigen-DR-compatible kidney transplantations. Associations with rejection incidence were tested in an a priori randomized training set and validation set.
Polymorphisms in TLR-3 (rs3775296) in the recipients and in ficolin-2 (rs7851696; Ala258Ser) and C1qR1 (rs7492) in the donors showed the strongest association with severe rejection. In multivariate analysis, presence of the ficolin-2 Ala258Ser variant in the donor predicted lower incidence of severe rejection (odds ratio=0.3; 95% confidence interval, 0.1-0.9; P=0.024) and of graft loss (hazard ratio=0.5; 95% confidence interval, 0.2-1.0; P=0.046) independently of clinical risk factors. Ficolin-2 messenger RNA expression was detected in pretransplantation biopsies from 69 donor grafts. Serum and tissue ficolin-2 levels were unaffected by genotype. Ficolin-2 protein, which bound to dying cells, was detected in donor kidneys in a passenger leukocyte-like pattern. Indeed, monocytes, monocyte-derived macrophages, and peripheral blood mononuclear cells expressed ficolin-2. Donor grafts with the ficolin-2 Ala258Ser variant contained significantly elevated expression of interleukin 6, having ascribed cytoprotective effects. It has been described that Ala258Ser leads to increased binding capacity of ficolin-2 to N-acetylglucosamine.
Presence of the ficolin-2 Ala258Ser polymorphism in the donor independently predicts improved graft outcome. Based on mechanistic data, we propose that this functional polymorphism leads to more efficient handling of injured cells by phagocytozing cells, resulting in decreased intragraft exposure to danger signals and dampened alloimmune responses.
先天免疫在控制适应性免疫反应中发挥作用。
我们在总共 520 对死后人类白细胞抗原-DR 相容的肾移植受者-供者对中,研究了 22 个编码先天、分泌和信号转导模式识别受体的基因中的单核苷酸多态性与临床的相关性。在一个预先设定的随机训练集和验证集中测试了与排斥反应发生率的相关性。
受体中的 TLR-3(rs3775296)、供体中的 ficolin-2(rs7851696;Ala258Ser)和 C1qR1(rs7492)的多态性与严重排斥反应的相关性最强。在多变量分析中,供体中 ficolin-2 Ala258Ser 变体的存在预测严重排斥反应的发生率较低(比值比=0.3;95%置信区间,0.1-0.9;P=0.024)和移植物丢失的发生率(风险比=0.5;95%置信区间,0.2-1.0;P=0.046),与临床危险因素无关。在 69 个供体移植物的移植前活检中检测到 ficolin-2 信使 RNA 表达。血清和组织 ficolin-2 水平不受基因型影响。结合死亡细胞的 ficolin-2 蛋白在供体肾脏中以过客白细胞样模式存在。事实上,单核细胞、单核细胞衍生的巨噬细胞和外周血单核细胞表达 ficolin-2。含有 ficolin-2 Ala258Ser 变体的供体移植物中白细胞介素 6 的表达显著升高,具有细胞保护作用。已经描述过 Ala258Ser 导致 ficolin-2 与 N-乙酰葡萄糖胺的结合能力增加。
供体中 ficolin-2 Ala258Ser 多态性的存在独立预测移植物预后改善。基于机制数据,我们提出这种功能多态性导致吞噬细胞更有效地处理受损细胞,从而减少移植物内暴露于危险信号和减弱同种免疫反应。